Alexey V Danilov (Alexey Danilov)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 24

Top Topics

Left Atrial Appendage

Diffuse Large B Cell Lymphoma

Tyrosine Kinase

Chronic Lymphocytic Leukemia

Top Venues

Blood cancer journal

Molecular cancer therapeutics

Molecular cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Tiana Huynh, Sonia Rodriguez-Rodriguez, Alexey V Danilov
Bruton Tyrosine Kinase Degraders in B-Cell Malignancies. Molecular cancer therapeutics 23 (5) (2024)
Prajish Iyer, Bo Zhang, Tingting Liu, Meiling Jin, Kevyn Lopez Hart, Jibin Zhang, Viola Siegert, Marianne Remke, Xuesong Wang, Lei Yu, Joo Y Song, Girish Venkataraman, Wing C Chan, Zhenyu Jia, Maike Buchner, Tanya Siddiqi, Steven T Rosen, Alexey V Danilov, Lili Wang
MGA deletion leads to Richter's transformation by modulating mitochondrial OXPHOS. Science translational medicine 16 (758) (2024)
Prajish Iyer, Bo Zhang, Tingting Liu, Meiling Jin, Kevyn Lopez Hart, Jibin Zhang, Viola Siegert, Marianne Remke, Xuesong Wang, Lei Yu, Joo Y Song, Girish Venkataraman, Wing C Chan, Zhenyu Jia, Maike Buchner, Tanya Siddiqi, Steven T Rosen, Alexey V Danilov, Lili Wang
MGA deletion leads to Richter's transformation by modulating mitochondrial OXPHOS. Science translational medicine 16 (758) (2024)
Paolo Lopedote, Adam S Kittai, Alexey V Danilov
Utilizing risk factors to guide treatment decisions in chronic lymphocytic leukemia. Expert review of anticancer therapy (2024)
Tiana Huynh, Sonia Rodriguez-Rodriguez, Alexey V Danilov
Bruton Tyrosine Kinase Degraders in B-Cell Malignancies. Molecular cancer therapeutics 23 (5) (2024)
Pallawi Torka, Swetha Kambhampati, Lu Chen, Xiaoguang Wang, Canping Chen, Dan Vuong, Hanjun Qin, Alexandra Muir, Kirsten Orand, Ivana Borja, D Lynne Smith, Alex F Herrera, Stephen E F Spurgeon, Byung Park, Lionel D Lewis, Francisco Hernandez-Ilizaliturri, Zheng Xia, Alexey V Danilov
Pevonedistat, a Nedd8-activating enzyme inhibitor, in combination with ibrutinib in patients with relapsed/refractory B-cell non-Hodgkin lymphoma. Blood cancer journal 13 (1) (2023)
Vi Lam, Carly Roleder, Tingting Liu, Nur Bruss, Scott Best, Xiaoguang Wang, Tycel Jovelle Phillips, Geoffrey Shouse, Allison J Berger, Lapo Alinari, Lili Wang, Tanya Siddiqi, Nathan D Pennock, Alexey V Danilov
T cell-intrinsic immunomodulatory effects of TAK-981 (subasumstat), a SUMO-activating enzyme inhibitor, in chronic lymphocytic leukemia. Molecular cancer therapeutics (2023)
Elana Thieme, Nur Bruss, Duanchen Sun, Edward C Dominguez, Daniel Coleman, Tingting Liu, Carly Roleder, Melissa Martinez, Krystine Garcia-Mansfield, Brian Ball, Patrick Pirrotte, Lili Wang, Zheng Xia, Alexey V Danilov
CDK9 inhibition induces epigenetic reprogramming revealing strategies to circumvent resistance in lymphoma. Molecular cancer 22 (1) (2023)
Edward C Dominguez, Carly Roleder, Brian Ball And, Alexey V Danilov
Cyclin-dependent kinase-9 in B-cell malignancies: pathogenic role and therapeutic implications. Leukemia & lymphoma (2023)
Elana Thieme, Nur Bruss, Duanchen Sun, Edward C Dominguez, Daniel Coleman, Tingting Liu, Carly Roleder, Melissa Martinez, Krystine Garcia-Mansfield, Brian Ball, Patrick Pirrotte, Lili Wang, Zheng Xia, Alexey V Danilov
CDK9 inhibition induces epigenetic reprogramming revealing strategies to circumvent resistance in lymphoma. Molecular cancer 22 (1) (2023)
Pallawi Torka, Swetha Kambhampati, Lu Chen, Xiaoguang Wang, Canping Chen, Dan Vuong, Hanjun Qin, Alexandra Muir, Kirsten Orand, Ivana Borja, D Lynne Smith, Alex F Herrera, Stephen E F Spurgeon, Byung Park, Lionel D Lewis, Francisco Hernandez-Ilizaliturri, Zheng Xia, Alexey V Danilov
Pevonedistat, a Nedd8-activating enzyme inhibitor, in combination with ibrutinib in patients with relapsed/refractory B-cell non-Hodgkin lymphoma. Blood cancer journal 13 (1) (2023)
Pallawi Torka, Swetha Kambhampati, Lu Chen, Xiaoguang Wang, Canping Chen, Dan Vuong, Hanjun Qin, Alexandra Muir, Kirsten Orand, Ivana Borja, D Lynne Smith, Alex F Herrera, Stephen E F Spurgeon, Byung Park, Lionel D Lewis, Francisco Hernandez-Ilizaliturri, Zheng Xia, Alexey V Danilov
Pevonedistat, a Nedd8-activating enzyme inhibitor, in combination with ibrutinib in patients with relapsed/refractory B-cell non-Hodgkin lymphoma. Blood cancer journal 13 (1) (2023)
Xiaoguang Wang, Canping Chen, Dan Vuong, Sonia Rodriguez-Rodriguez, Vi Lam, Carly Roleder, Jing Hong Wang, Swetha Kambhampati, Allison Berger, Nathan D Pennock, Pallawi Torka, Francisco Hernandez-Ilizaliturri, Tanya Siddiqi, Lili Wang, Zheng Xia, Alexey V Danilov
Pharmacologic targeting of Nedd8-activating enzyme reinvigorates T-cell responses in lymphoid neoplasia. Leukemia (2023)
Pallawi Torka, Swetha Kambhampati, Lu Chen, Xiaoguang Wang, Canping Chen, Dan Vuong, Hanjun Qin, Alexandra Muir, Kirsten Orand, Ivana Borja, D Lynne Smith, Alex F Herrera, Stephen E F Spurgeon, Byung Park, Lionel D Lewis, Francisco Hernandez-Ilizaliturri, Zheng Xia, Alexey V Danilov
Pevonedistat, a Nedd8-activating enzyme inhibitor, in combination with ibrutinib in patients with relapsed/refractory B-cell non-Hodgkin lymphoma. Blood cancer journal 13 (1) (2023)
Pallawi Torka, Swetha Kambhampati, Lu Chen, Xiaoguang Wang, Canping Chen, Dan Vuong, Hanjun Qin, Alexandra Muir, Kirsten Orand, Ivana Borja, D Lynne Smith, Alex F Herrera, Stephen E F Spurgeon, Byung Park, Lionel D Lewis, Francisco Hernandez-Ilizaliturri, Zheng Xia, Alexey V Danilov
Pevonedistat, a Nedd8-activating enzyme inhibitor, in combination with ibrutinib in patients with relapsed/refractory B-cell non-Hodgkin lymphoma. Blood cancer journal 13 (1) (2023)
Yiming Wu, Meiling Jin, Mike Minh Fernandez, Kevyn Lopez Hart, Aijun Liao, Xinzhou Ge, Stacey M Fernandes, Tinisha McDonald, Zhenhua Chen, Daniel Röth, Lucy Y Ghoda, Guido Marcucci, Markus Kalkum, Raju K Pillai, Alexey V Danilov, Jingyi Jessica Li, Jianjun Chen, Jennifer R Brown, Steven T Rosen, Tanya Siddiqi, Lili Wang
METTL3-Mediated m6A Modification Controls Splicing Factor Abundance and Contributes to Aggressive CLL. Blood cancer discovery (2023)
Elana Thieme, Nur Bruss, Duanchen Sun, Edward C Dominguez, Daniel Coleman, Tingting Liu, Carly Roleder, Melissa Martinez, Krystine Garcia-Mansfield, Brian Ball, Patrick Pirrotte, Lili Wang, Zheng Xia, Alexey V Danilov
CDK9 inhibition induces epigenetic reprogramming revealing strategies to circumvent resistance in lymphoma. Molecular cancer 22 (1) (2023)
Darcy B Pooler, Dylan B Ness, Alexey V Danilov, Bridget M Labrie, Tor D Tosteson, Alan Eastman, Lionel D Lewis, Frederick Lansigan
A phase I trial of BNC105P and ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia. EJHaem 3 (4) (2022)
Elana Thieme, Tingting Liu, Nur Bruss, Carly Roleder, Vi Lam, Xiaoguang Wang, Tamilla Nechiporuk, Geoffrey Shouse, Olga V Danilova, Daniel Bottomly, Shannon K McWeeney, Jeffrey W Tyner, Stephen E Kurtz, Alexey V Danilov
Dual BTK/SYK inhibition with CG-806 (luxeptinib) disrupts B-cell receptor and Bcl-2 signaling networks in mantle cell lymphoma. Cell death & disease 13 (3) (2022)
Vi Lam, Scott Best, Adam Kittai, Kirsten Orand, Stephen E Spurgeon, Tingting Liu, Alexey V Danilov
Proapoptotic and immunomodulatory effects of SYK inhibitor entospletinib in combination with obinutuzumab in patients with chronic lymphocytic leukaemia. British journal of clinical pharmacology (2021)
Reem Karmali, Jeffrey M Switchenko, Subir Goyal, Krithika Shanmugasundaram, Michael C Churnetski, Bhaskar Kolla, Veronika Bachanova, James N Gerson, Stefan K Barta, Max J Gordon, Alexey V Danilov, Natalie S Grover, Narendranath Epperla, Stephanie Mathews, Madelyn Burkart, Yazeed Sawalha, Brian T Hill, Nilanjan Ghosh, Steven I Park, David A Bond, Kami J Maddocks, Talha Badar, Timothy S Fenske, Mehdi Hamadani, Jin Guo, Mary Malecek, Brad S Kahl, Peter Martin, Kristie A Blum, Christopher R Flowers, Jonathon B Cohen
Multi-center analysis of practice patterns and outcomes of younger and older patients with mantle cell lymphoma in the rituximab era. American journal of hematology 96 (11) (2021)
Scott Best, Vi Lam, Tingting Liu, Nur Bruss, Adam Kittai, Olga V Danilova, Susan Murray, Allison Berger, Nathan D Pennock, Evan F Lind, Alexey V Danilov
Immunomodulatory effects of pevonedistat, a NEDD8-activating enzyme inhibitor, in chronic lymphocytic leukemia-derived T cells. Leukemia 35 (1) (2020)
Christopher A Eide, Stephen E Kurtz, Andy Kaempf, Nicola Long, Anupriya Agarwal, Cristina E Tognon, Motomi Mori, Brian J Druker, Bill H Chang, Alexey V Danilov, Jeffrey W Tyner
Simultaneous kinase inhibition with ibrutinib and BCL2 inhibition with venetoclax offers a therapeutic strategy for acute myeloid leukemia. Leukemia 34 (9) (2020)
Alexey V Danilov, Daniel O Persky
Incorporating acalabrutinib, a selective next-generation Bruton tyrosine kinase inhibitor, into clinical practice for the treatment of haematological malignancies. British journal of haematology 193 (1) (2020)